Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Oncology Pubmed
 
/lp/pubmed/neoadjuvant-chemoradiotherapy-plus-surgery-versus-surgery-alone-for-0piVyOI8Xi

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1470-2045
DOI
10.1016/S1470-2045(15)00040-6
pmid
26254683

Abstract

Journal

The Lancet OncologyPubmed

Published: Dec 14, 2015

There are no references for this article.